Shevach, J., Gallagher, E., Kochukoshy, T., Gresia, V., Brar, M., Galsky, M. D., & Oh, W. K. (2015). Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer. In Journal of Clinical Oncology (Vol. 33, pp. e16036–e16036). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.e16036

Shevach, Jeffrey, Emily Gallagher, Teena Kochukoshy, Victoria Gresia, Manpreet Brar, Matt D. Galsky, and William K. Oh. “Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer.” In Journal of Clinical Oncology, 33:e16036–e16036. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.e16036.

Shevach J, Gallagher E, Kochukoshy T, Gresia V, Brar M, Galsky MD, et al. Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e16036–e16036.

Shevach, Jeffrey, et al. “Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. e16036–e16036. Crossref, doi:10.1200/jco.2015.33.15_suppl.e16036.

Shevach J, Gallagher E, Kochukoshy T, Gresia V, Brar M, Galsky MD, Oh WK. Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e16036–e16036.